JP2010037221A5 - - Google Patents

Download PDF

Info

Publication number
JP2010037221A5
JP2010037221A5 JP2008198731A JP2008198731A JP2010037221A5 JP 2010037221 A5 JP2010037221 A5 JP 2010037221A5 JP 2008198731 A JP2008198731 A JP 2008198731A JP 2008198731 A JP2008198731 A JP 2008198731A JP 2010037221 A5 JP2010037221 A5 JP 2010037221A5
Authority
JP
Japan
Prior art keywords
propolis
aqueous solution
active ingredient
extract obtained
oral ingestion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008198731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010037221A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2008198731A priority Critical patent/JP2010037221A/ja
Priority claimed from JP2008198731A external-priority patent/JP2010037221A/ja
Publication of JP2010037221A publication Critical patent/JP2010037221A/ja
Publication of JP2010037221A5 publication Critical patent/JP2010037221A5/ja
Pending legal-status Critical Current

Links

JP2008198731A 2008-07-31 2008-07-31 アディポネクチン産生増強剤 Pending JP2010037221A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008198731A JP2010037221A (ja) 2008-07-31 2008-07-31 アディポネクチン産生増強剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008198731A JP2010037221A (ja) 2008-07-31 2008-07-31 アディポネクチン産生増強剤

Publications (2)

Publication Number Publication Date
JP2010037221A JP2010037221A (ja) 2010-02-18
JP2010037221A5 true JP2010037221A5 (enExample) 2011-09-15

Family

ID=42010126

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008198731A Pending JP2010037221A (ja) 2008-07-31 2008-07-31 アディポネクチン産生増強剤

Country Status (1)

Country Link
JP (1) JP2010037221A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4750213B1 (ja) * 2010-05-21 2011-08-17 株式会社 ファイナルフューチャーインターナショナル アディポネクチン産生促進組成物
US20130123206A1 (en) * 2010-07-30 2013-05-16 Michael J. Quon Treatment of metabolic syndrome and insulin resistance with citrus flavanones
JP5919241B2 (ja) * 2013-10-10 2016-05-18 学校法人愛知学院 レチノイドｘ受容体アゴニスト剤
CN111505317B (zh) * 2020-04-21 2023-09-29 江西乐成生物医疗有限公司 脂联素测定试剂质控品及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4541635B2 (ja) * 2002-07-12 2010-09-08 株式会社ファンケル トロンボキサンａ２合成酵素阻害剤
JP2005225872A (ja) * 2004-01-15 2005-08-25 National Institute Of Advanced Industrial & Technology アディポネクチン産生増進剤
JP2006273839A (ja) * 2005-03-04 2006-10-12 National Institute Of Advanced Industrial & Technology アディポネクチン産生増進剤
JP2007063203A (ja) * 2005-08-31 2007-03-15 Nof Corp 糖尿病改善剤
JP2007091672A (ja) * 2005-09-29 2007-04-12 Nof Corp アディポネクチン上昇剤
JP5246834B2 (ja) * 2005-12-27 2013-07-24 独立行政法人産業技術総合研究所 アディポネクチン産生強化剤

Similar Documents

Publication Publication Date Title
IT1393045B1 (it) Composizioni contenenti monogliceridi di acidi organici da c1 a c7 e glicerolo, loro preparazione ed uso come antibatterici in zootecnia.
MA32383B1 (fr) DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE
MY183312A (en) Pharmaceutical formulation
CR20130259A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
EA201692443A1 (ru) Водная фармацевтическая композиция тапентадола для перорального введения
WO2010141693A3 (en) Borinic compositions
BR112013011997A2 (pt) "métodos para produzir uma solução aquosa concentrada de açúcar e para produzir etanol como uso de uma levedura"
JP2009537554A5 (enExample)
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
JO3112B1 (ar) تركيبة دوائية سريعة التحلل
BRPI0917502A2 (pt) composição farmacêtica, e, métodos para usar um ácido orgânico ou um antioxidante, para evitar a descoloração causada quando ácido tranemaxâmico e ácido ascórbico são incorporados em uma mesma composição, e para produzir uma preparação farmacêutica sólida para administração oral
AR074545A1 (es) Proceso de preparacion de dihidroetorfina
JP2010037221A5 (enExample)
JP2013005790A5 (enExample)
IL208151A0 (en) Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate
JP2013119547A5 (enExample)
JP2013536814A5 (enExample)
EP2335698B8 (en) Pharmaceutical solid preparation having active ingredients separated by boundary therein
WO2010134048A3 (en) Topical retinoid solutions
WO2012150607A3 (en) Oral liquid composition comprising divalproex sodium and process for preparing thereof
JP2014533689A5 (enExample)
RU2005126107A (ru) Гепатопротекторное средство, обладающее антиоксидантной активностью и способ его получения
JP2009108050A5 (enExample)
JP2009114179A5 (enExample)